Alzheimer’s disease is a degenerative disorder that affects brain functions such as memory, thinking, language, judgment, and behavior. It is the 6th leading cause of death worldwide. Therefore, developing new and effective treatments for Alzheimer’s is crucial. Our studies aim to make progress in the treatment of Alzheimer’s disease.
Our research centers are currently recruiting individuals with Alzheimer’s Disease for research studies. We are looking for both men and women between the ages of 50 and 85 who have been diagnosed or show symptoms related to Alzheimer’s. All study-related visits, lab work, medication, and procedures, including physical exams, will be provided at no cost to those who meet the qualifications for the study. Eligible participants will also receive compensation for their time and travel. Additional criteria for eligibility will be discussed with interested individuals, without any obligation, when they contact the nearest research center. You can find contact information on our website.
If you or someone you know has Alzheimer’s Disease, they may qualify for a research study. Our studies aim to evaluate the safety and effectiveness of an experimental drug for treating the disease. To learn more, please reach out to us for more information.
Our mission at Scranton Medical Institute (SMI) is to disseminate cutting-edge research to the people of Pennsylvania. We give you access to healthcare services that aren’t presently provided to the general public. Trials are entirely free, and people who take part may be compensated.
OFFICE HOURS:
Mon-Fri: 9:00 AM – 5:30 PM
Sat-Sun: Closed
CONTACT INFO:
Phone: 570-346-3686
Fax: 570-344-1085
ADDRESS:
340 Montage Mountain Road
Moosic, PA 18507